Norfolk Southern Corporation · NSC · FY2025 Q4 · Calendar Q1 2026
Norfolk Southern: Safety and productivity gains offset soft volumes
Norfolk Southern's latest call supports a mixed thesis: safety, productivity, merchandise demand and digital tools provide operating support, but soft volumes, coal pricing and merger uncertainty limit confidence in a stronger near-term trajectory.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about NSC FY2025 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The latest analysis shifted emphasis toward cautious execution: safety performance and productivity improved, while revenue stayed flat, capital spending was reduced, and management continued to navigate soft demand and the pending merger.
Guidance delta
Cost guidance was maintained, while the capital plan was reduced; the broader outlook remained cautious rather than materially upgraded.
Key takeaways
- Management highlighted stronger safety and service reliability alongside productivity gains.
- Revenue conditions remained mixed: merchandise demand helped, while softer volumes and coal pricing weighed.
- The investment case remains tied to cost control, digital inspection tools, new services, and merger progress.
Management priorities
- Maintain safety and network reliability.
- Advance cost-takeout initiatives and digital inspection capabilities.
- Progress the Union Pacific merger through regulatory review and integration planning.
Follow NSC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 1, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 27, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 27, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 24, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 24, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 24, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 24, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | Jul 14, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Apr 27, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Mar 31, 2026 |
| Deutsche Bank | Hold | Buy | Downgrade | Dec 11, 2025 |
| UBS | Buy | Buy | Maintain | Oct 24, 2025 |
| Benchmark | Hold | Buy | Downgrade | Jul 30, 2025 |
| Jefferies | Hold | Buy | Downgrade | Jul 25, 2025 |
| B of A Securities | Buy | Buy | Maintain | Jul 17, 2025 |
| Goldman Sachs | Neutral | Buy | Downgrade | Jun 2, 2025 |
| Stifel | Hold | Hold | Maintain | Apr 14, 2025 |
| Loop Capital | Hold | Buy | Downgrade | Feb 3, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jan 30, 2025 |
| Morgan Stanley | Underweight | Equal Weight | Downgrade | Jan 29, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 27, 2023 |
| Argus Research | Hold | Buy | Downgrade | Mar 15, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Feb 21, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 26, 2023 |
| Bank of America | Neutral | Neutral | Maintain | Sep 30, 2020 |
| TD Securities | Buy | Hold | Upgrade | Oct 25, 2018 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Oct 25, 2018 |
| Argus | Buy | Buy | Maintain | Jul 31, 2018 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Jan 12, 2018 |
| Buckingham | Neutral | Neutral | Maintain | Jan 18, 2017 |
| Seaport Global | Buy | Buy | Maintain | Oct 28, 2016 |
| Avondale Partners | Underperform | Market Outperform | Downgrade | Oct 12, 2016 |
| Atlantic Equities | Neutral | Neutral | Maintain | Aug 11, 2016 |
| Oppenheimer | Perform | Market Perform | Maintain | Jun 16, 2016 |
| CLSA | Outperform | Outperform | Maintain | May 19, 2016 |
| Nomura | Neutral | Neutral | Maintain | Apr 22, 2016 |
| Macquarie | Underperform | Underperform | Maintain | Jan 28, 2016 |
| Buckingham Research | Neutral | Buy | Downgrade | Jan 28, 2016 |
| Topeka Capital | Hold | Hold | Maintain | Nov 25, 2015 |
| Topeka | Hold | Hold | Maintain | Nov 25, 2015 |
| Cleveland Research | Neutral | Neutral | Maintain | Mar 26, 2015 |
| Raymond James | Outperform | Outperform | Maintain | Jul 24, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Jun 24, 2014 |
| Dahlman Rose | Buy | Hold | Upgrade | Feb 4, 2013 |
| Sterne Agee | Buy | Buy | Maintain | Oct 24, 2012 |
| BB&T Capital | Buy | Hold | Upgrade | Jul 2, 2012 |
| Bank oferica | Buy | Buy | Maintain | Apr 25, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $309. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Walter Spracklin | $330 | $316.16 | +6.8% | Sep 24, 2026 |
| BMO Capital | Analyst unavailable | $355 | $350.66 | +14.9% | Jul 27, 2026 |
| Robert W. Baird | Analyst unavailable | $377 | $350.66 | +22.0% | Jul 27, 2026 |
| UBS | Analyst unavailable | $363 | $347.99 | +17.5% | Jul 24, 2026 |
| Barclays | Brandon Oglenski | $400 | $348.55 | +29.4% | Jul 24, 2026 |
| Evercore ISI | Analyst unavailable | $358 | $348.55 | +15.9% | Jul 23, 2026 |
| Susquehanna | Analyst unavailable | $360 | $327.45 | +16.5% | Jul 14, 2026 |
| Robert W. Baird | Analyst unavailable | $360 | $323.77 | +16.5% | Jul 10, 2026 |
| Susquehanna | Analyst unavailable | $337 | $313.4 | +9.1% | Jun 5, 2026 |
| UBS | Analyst unavailable | $327 | $315.7 | +5.8% | May 7, 2026 |
| Robert W. Baird | Daniel Moore | $330 | $318.81 | +6.8% | Apr 28, 2026 |
| BMO Capital | Analyst unavailable | $310 | $318.02 | +0.3% | Apr 27, 2026 |
| RBC Capital | Walter Spracklin | $360 | $319.58 | +16.5% | Apr 27, 2026 |
| Barclays | Analyst unavailable | $360 | $319.58 | +16.5% | Apr 27, 2026 |
| Evercore ISI | Analyst unavailable | $325 | $319.58 | +5.2% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $310 | $283.28 | +0.3% | Mar 26, 2026 |
| UBS | Analyst unavailable | $342 | $306.91 | +10.7% | Feb 6, 2026 |
| Robert W. Baird | Analyst unavailable | $288 | $291.07 | -6.8% | Feb 2, 2026 |
| RBC Capital | Analyst unavailable | $320 | $288.09 | +3.6% | Jan 30, 2026 |
| RBC Capital | Analyst unavailable | $325 | $294.43 | +5.2% | Dec 18, 2025 |
| Barclays | Analyst unavailable | $340 | $298.56 | +10.0% | Dec 16, 2025 |
| Deutsche Bank | Analyst unavailable | $297 | $294.26 | -3.9% | Dec 11, 2025 |
| Robert W. Baird | Analyst unavailable | $293 | $295.1 | -5.2% | Dec 5, 2025 |
| RBC Capital | Walter Spracklin | $315 | $281.5 | +1.9% | Oct 24, 2025 |
| BMO Capital | Analyst unavailable | $305 | $284 | -1.3% | Oct 24, 2025 |
| Barclays | Analyst unavailable | $320 | $298.68 | +3.6% | Oct 2, 2025 |
| Deutsche Bank | Analyst unavailable | $354 | $298.68 | +14.6% | Oct 1, 2025 |
| Susquehanna | Bascome Majors | $295 | $293.32 | -4.5% | Sep 25, 2025 |
| Susquehanna | Bascome Majors | $260 | $257.46 | -15.9% | Jun 24, 2025 |
| BMO Capital | Fadi Chamoun | $255 | $226.18 | -17.5% | Apr 24, 2025 |
| Deutsche Bank | Analyst unavailable | $293 | $242.22 | -5.2% | Mar 7, 2025 |
| Susquehanna | Bascome Majors | $265 | $237.76 | -14.2% | Jan 8, 2025 |
| Loop Capital Markets | Ric Paterson | $287 | $260.43 | -7.1% | Oct 23, 2024 |
| Susquehanna | Bascome Majors | $285 | $260.43 | -7.8% | Oct 23, 2024 |
| RBC Capital | Walter Spracklin | $282 | $260.43 | -8.7% | Oct 23, 2024 |
| Wells Fargo | Christian Wetherbee | $280 | $260.43 | -9.4% | Oct 23, 2024 |
| UBS | Thomas Wadewitz | $309 | $260.43 | +0.0% | Oct 23, 2024 |
| Jefferies | Stephanie Moore | $285 | $260.43 | -7.8% | Oct 22, 2024 |
| Barclays | Brandon Oglenski | $290 | $260.43 | -6.1% | Oct 22, 2024 |
| Citigroup | Ariel Rosa | $302 | $261.62 | -2.3% | Oct 22, 2024 |
| CFRA | Emily Nasseff Mitsch | $248 | $261.46 | -19.7% | Oct 22, 2024 |
| Barclays | Brandon Oglenski | $275 | $253.77 | -11.0% | Sep 12, 2024 |
| Loop Capital Markets | Ric Paterson | $285 | $248.44 | -7.8% | Jul 29, 2024 |
| Goldman Sachs | Jordan Alliger | $292 | $246.97 | -5.5% | Jul 26, 2024 |
| RBC Capital | Walter Spracklin | $267 | $249.67 | -13.6% | Jul 26, 2024 |
| Bernstein | David Vernon | $285 | $215.86 | -7.8% | Jul 8, 2024 |
| Morgan Stanley | Ravi Shanker | $175 | $215.86 | -43.4% | Jul 8, 2024 |
| UBS | Thomas Wadewitz | $294 | $236.22 | -4.9% | Apr 25, 2024 |
| Stifel Nicolaus | Benjamin Nolan | $244 | $249.73 | -21.0% | Apr 12, 2024 |
| RBC Capital | Walter Spracklin | $270 | $248.77 | -12.6% | Apr 10, 2024 |
| Jefferies | Stephanie Moore | $300 | $250.03 | -2.9% | Apr 8, 2024 |
| UBS | Thomas Wadewitz | $302 | $261.23 | -2.3% | Mar 20, 2024 |
| Stifel Nicolaus | Benjamin Nolan | $233 | $261.23 | -24.6% | Mar 20, 2024 |
| Barclays | Brandon Oglenski | $305 | $257.62 | -1.3% | Feb 21, 2024 |
| Citigroup | Christian Wetherbee | $225 | $237.85 | -27.2% | Jan 26, 2024 |
| Bernstein | David Vernon | $272 | $240.14 | -12.0% | Jan 22, 2024 |
| Barclays | Analyst unavailable | $255 | $254.07 | -17.5% | Dec 5, 2022 |
| Wells Fargo | Analyst unavailable | $285 | $256.5 | -7.8% | Dec 1, 2022 |
| Citigroup | Analyst unavailable | $250 | $248.55 | -19.1% | Nov 29, 2022 |
| Deutsche Bank | Analyst unavailable | $273 | $248.55 | -11.7% | Nov 29, 2022 |
| Credit Suisse | Analyst unavailable | $278 | $250.66 | -10.0% | Nov 22, 2022 |
| Morgan Stanley | Ravi Shanker | $177 | $222.12 | -42.7% | Oct 27, 2022 |
| Robert W. Baird | Garrett Holland | $240 | $218.93 | -22.3% | Oct 7, 2022 |
| Susquehanna | Bascome Majors Majors | $218 | $214.55 | -29.4% | Sep 29, 2022 |
| Stifel Nicolaus | Benjamin Nolan | $275 | $221.7 | -11.0% | Jul 15, 2022 |
| BMO Capital | Analyst unavailable | $285 | $263.96 | -7.8% | Apr 28, 2022 |
| UBS | Thomas Wadewitz | $335 | $268.56 | +8.4% | Jan 27, 2022 |
| Wolfe Research | Scott Group | $320 | $268.56 | +3.6% | Jan 27, 2022 |
| Cowen & Co. | Jason Seidl | $321 | $267.84 | +3.9% | Jan 26, 2022 |
| Goldman Sachs | Jordan Alliger | $320 | $267.84 | +3.6% | Jan 26, 2022 |
| Citigroup | Christian Wetherbee | $345 | $293.4 | +11.7% | Jan 5, 2022 |
| Benchmark Co. | Nathan Martin | $316 | $290.76 | +2.3% | Oct 28, 2021 |
| TD Securities | Cherilyn Radbourne | $330 | $290.76 | +6.8% | Oct 28, 2021 |
| Stifel Nicolaus | Benjamin Nolan | $278 | $253.72 | -10.0% | Jul 28, 2021 |
| Evercore ISI | Jonathan Chappell | $303 | $260.36 | -1.9% | Jul 9, 2021 |
| Argus Research | John Eade | $310 | $283.12 | +0.3% | May 4, 2021 |
| Loop Capital Markets | Rick Paterson | $321 | $276.25 | +3.9% | Apr 29, 2021 |
Track every rating change on NSC the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationNorfolk Southern Corporation (NSC), operating through its various subsidiaries, is a prominent rail transport provider in the United States. The company's core business involves the conveyance of raw materials, semi-finished goods, and completed merchandise across the nation. Its extensive freight services cover a broad spectrum of commodities. This includes a variety of agricultural and forestry products like grains (e.g., soybeans, wheat, corn), fertilizers, animal feeds, and diverse foodstuffs such as oils, flour, sweeteners, beverages, and canned goods, alongside lumber and paper products. NSC also handles a wide range of chemicals, from sulfur and petroleum derivatives to chlorine compounds, plastics, industrial chemicals, and sand.…
Historical context
All NSC earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- CCLFY2026 Q3 · September 29, 2026+5.9% EPS+13.4% move
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
Get the NSC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-10-01T08:46:08.183199+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-01T08:46:08.180224+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-01. For educational purposes only; not investment advice.